Kiel researchers show that immune cells targeting Candida albicans most likely originate in the oral mucosa and acquire harmful properties in chronic intestinal inflammation — a new starting point for therapy.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Immunantwort auf eigentlich harmlosen Hefepilz wird bei Morbus Crohn zum Problem | 0 | 8 | 14-07-2026 |
| 2 | This 5-day diet helped Crohn’s patients feel better fast | 0 | 9.21 | 03-04-2026 |
| 3 | How chronic intestinal inflammation can affect the heart | 0 | 5.24 | 13-10-2026 |
| 4 | Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease | 0 | 8.4 | 11-06-2026 |
| 5 | Changing when you eat dramatically reduced Crohn’s disease symptoms | 0 | 9.69 | 12-02-2026 |
| 6 | Yeast dietary supplement may offer a safe nutritional strategy to boost cancer immunity | 5 | 7 | 09-07-2026 |
| 7 | Key gut protein balances immune protection and tolerance | 6 | 7 | 07-07-2026 |
| 8 | B cells may help predict risk of colitis from immunotherapy | 0 | 5.92 | 18-09-2026 |
| 9 | Scientists uncover how fungi 'blind' the immune system—offering new hope against superbugs | 5 | 7 | 08-07-2026 |
| 10 | Therapeutic target for dangerous fungal infections identified | 6 | 7 | 17-06-2026 |